List of works by Kristi L Berger

Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis C.

scientific article published on 15 July 2013

Baseline hepatitis C virus (HCV) NS3 polymorphisms and their impact on treatment response in clinical studies of the HCV NS3 protease inhibitor faldaprevir

scientific article published on 11 November 2013

Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras

scientific article

Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides

scientific article

Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis

scientific article

Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication.

scientific article

Molecular determinants and dynamics of hepatitis C virus secretion

scientific article

Possibilities for RNA interference in developing hepatitis C virus therapeutics

scientific article

Potential roles for cellular cofactors in hepatitis C virus replication complex formation

scientific article

Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism

scholarly article

RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis

scientific article

Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir

scientific article published on 5 August 2016

Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication

scientific article

Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection

scientific article published on 6 May 2016

Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes.

scientific article published on September 2002

Viral resistance in hepatitis C virus genotype 1-infected patients receiving the NS3 protease inhibitor Faldaprevir (BI 201335) in a phase 1b multiple-rising-dose study

scientific article published on 22 July 2013